Development of Potent G Protein Pathway-Biased GPR183 Agonists
Kaustubh R. Bhuskute, Asmita Manandhar, Viktoria M. S. Kjær, Francesco Casartelli, Gertrud M. Hjortø, Maria Ioanna Koutsaki, Udhayabhaskar Sathyanarayanan, Emilia Hjortkilde, Rita Turcio, METTE MARIE ROSENKILDE, Trond Ulven, Elisabeth Rexen Ulven
This paper develops potent G protein-biased GPR183 agonists with low nanomolar potency and complete Gi protein bias, showing distinct biological effects compared to the natural ligand.
Journal of Medicinal Chemistry · Oct 9, 2026Peer-reviewedPharmacology & Toxicology